Deutsche Märkte schließen in 4 Stunden 58 Minuten

Evogene Ltd. (EVGN)

NasdaqCM - NasdaqCM Echtzeitpreis. Währung in USD
Zur Watchlist hinzufügen
0,6597+0,0048 (+0,73%)
Börsenschluss: 04:00PM EDT
0,6369 -0,02 (-3,46%)
Vorbörslich: 06:17AM EDT

Evogene Ltd.

13 Gad Feinstein Street
Park Rehovot PO Box 4173
Rehovot 7414002
Israel
972 8 931 1900
https://www.evogene.com

Sektor(en)Healthcare
BrancheBiotechnology
Vollzeitmitarbeiter142

Leitende Angestellte

NameTitelZahlenAusgeübtGeburtsjahr
Mr. Ofer Haviv CPACEO & President390kN/A1966
Dr. Nir ArbelChief Product Officer228kN/A1980
Dr. Brian EmberChief Executive Officer of AgPlenus Ltd287kN/A1976
Dr. Elran Hillel Haber M.B.A., Ph.D.Chief Executive Officer of Biomica Ltd302kN/A1980
Mr. Amit Noam Capt. res.Chief Executive Officer of Lavie Bio Ltd.136kN/A1982
Mr. Yaron EldadChief Financial OfficerN/AN/A1965
Mr. Mark KapelChief Technology Officer276kN/A1977
Rachel Pomerantz GerberHead of Investor RelationsN/AN/AN/A
Mr. Sassi MasliahVice President of Corporate Development245kN/A1979
Ms. Liat Foigel WejgmanVice President of Human ResourcesN/AN/AN/A
Die Beträge haben den Stand 31. Dezember 2023 und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Corporate Governance

Evogene Ltd.s ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.